Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Renal Genetic Laboratory, Hôpital du Sacré-Coeur de Montreal, Department of Medicine, University of Montreal, Montreal, Quebec, Canada.
J Clin Endocrinol Metab. 2022 May 17;107(6):e2513-e2522. doi: 10.1210/clinem/dgac076.
Familial pituitary diabetes insipidus has been described only in an autosomal dominant or recessive mode of inheritance.
This work aims to determine the cause of a novel form of familial diabetes insipidus (DI) that is controlled by desmopressin therapy but segregates in an X-linked recessive manner.
Thirteen members from 3 generations of the kindred with familial DI were studied. Water intake, urine volume, urine osmolality, plasma osmolality, and plasma vasopressin were measured under basal conditions, during fluid deprivation, 3% saline infusion, and water loading. Magnetic resonance images of the posterior pituitary also were obtained. In affected males, the effects of desmopressin therapy and linkage of the DI to markers for chromosome Xq28 were determined. In addition, the genes encoding vasopressin, aquaporin-2, the AVPR2 receptor, and its flanking regions were sequenced.
This study showed that 4 males from 3 generations of the kindred have DI that is due to a deficiency of vasopressin, is corrected by standard doses of desmopressin, and segregates with markers for the AVPR2 gene in Xq28. However, no mutations were found in AVPR2 or its highly conserved flanking regions. Exome sequencing confirmed these findings and also revealed no deleterious variants in the provasopressin and aquaporin-2 genes. The 4 obligate female carriers osmo-regulated vasopressin in the low normal range.
X-linked recessive transmission of DI can be due to a defect in either the secretion or the action of vasopressin. Other criteria are necessary to differentiate and manage the 2 disorders correctly.
家族性垂体性尿崩症仅以常染色体显性或隐性遗传模式描述。
本研究旨在确定一种新型家族性尿崩症(DI)的病因,该疾病受去氨加压素治疗控制,但呈 X 连锁隐性遗传方式。
对 3 代家族性 DI 患者的 13 名成员进行研究。在基础状态、液体剥夺、3%盐水输注和水负荷下测量水摄入量、尿量、尿渗透压、血浆渗透压和血浆血管加压素。还获得了后垂体的磁共振图像。在受影响的男性中,评估了去氨加压素治疗的效果以及 DI 与染色体 Xq28 标记物的连锁关系。此外,还对血管加压素、水通道蛋白-2、AVPR2 受体及其侧翼区域的基因进行了测序。
本研究表明,3 代家族中的 4 名男性患有 DI,这是由于血管加压素缺乏引起的,标准剂量的去氨加压素可纠正,并且与 Xq28 上的 AVPR2 基因标记物连锁。然而,在 AVPR2 或其高度保守的侧翼区域未发现突变。外显子组测序证实了这些发现,并且在 provasopressin 和 aquaporin-2 基因中也未发现有害变异。4 名强制性女性携带者的血管加压素在低正常范围内受到渗透压调节。
DI 的 X 连锁隐性遗传可能是由于血管加压素的分泌或作用缺陷所致。需要其他标准来正确区分和管理这两种疾病。